...
首页> 外文期刊>Frontiers in Pharmacology >Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype
【24h】

Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype

机译:Sirtuins在确定恶性表型方面的双重抑癌和促肿瘤作用

获取原文

摘要

Sirtuins (SIRTs), class III histone deacetylases, are differentially expressed in several human cancers, where they display both oncogenic and tumor-suppressive properties depending on cellular context and experimental conditions. SIRTs are involved in many important biological processes and play a critical role in cancer initiation, promotion, and progression. A growing body of evidence indicates the involvement of SIRTs in regulating three important tumor processes: epithelial-to-mesenchymal transition (EMT), invasion, and metastasis. Many SIRTs are responsible for cellular metabolic reprogramming and drug resistance by inactivating cell death pathways and promoting uncontrolled proliferation. In this review, we summarize current knowledge on the role of SIRTs in cancer and discuss their puzzling dual function as tumor suppressors and tumor promoters, important for the future development of novel tailored SIRT-based cancer therapies.
机译:Sirtuins(SIRTs),III类组蛋白脱乙酰基酶,在几种人类癌症中差异表达,它们根据细胞环境和实验条件显示出致癌和抑癌特性。 SIRTs参与许多重要的生物学过程,并在癌症的引发,促进和发展中发挥关键作用。越来越多的证据表明,SIRTs参与调节三个重要的肿瘤过程:上皮-间充质转化(EMT),侵袭和转移。许多SIRT通过失活细胞死亡途径并促进不受控制的增殖来负责细胞代谢重编程和耐药性。在这篇综述中,我们总结了关于SIRT在癌症中的作用的当前知识,并讨论了它们令人困惑的双重作用,即抑癌和促肿瘤作用,这对基于SIRT的新型定制癌症疗法的未来发展至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号